Cutis Lux

LYMA Laser vs Tria FRX

LYMA Laser and Tria FRX compared on published specifications. LYMA Laser is a low-level (“cold”) laser; Tria FRX is a non-ablative fractional laser. In use, LYMA Laser: no heat; the brand reports no pain or downtime. Tria FRX: warmth, prickling and short-lived redness are expected. They work in different ways, so they are not direct substitutes. LYMA Laser: 808 nm, session 3 min per area, £1,999. Tria FRX: 1440 nm, session 2–10 min, by setting, US$699.99.

Side by side

LYMA LaserTria FRX
TypeLaserLaser
TechnologyLow-level (“cold”) laserNon-ablative fractional laser
Wavelength808 nm1440 nm
Reported output500 mW continuous beamNot found on checked page (low, medium and high settings)
Form and coverageHandheld wand, 8 cm² diffused lensHandheld glide device; face only
Session3 min per area2–10 min, by setting
Schedule (brand)Daily for 12 weeks, then 3 times a week5 times a week for 12 weeks, then 4 weeks rest
Reference price£1,999US$699.99
FDA 510(k)K210823
Record names this device
K141868
Possible match, unconfirmed

Key differences

  • Both are home lasers, but LYMA Laser is a low-level (“cold”) laser and Tria FRX is a non-ablative fractional laser.
  • Wavelengths: LYMA Laser 808 nm; Tria FRX 1440 nm (none shared).
  • Sessions: LYMA Laser 3 min per area; Tria FRX 2–10 min, by setting.
  • Reported output: LYMA Laser 500 mW continuous beam; Tria FRX Not found on checked page (low, medium and high settings).
  • Reference price: LYMA Laser £1,999; Tria FRX US$699.99 (different currencies, not converted).
  • FDA record: LYMA Laser K210823 (record names this device); Tria FRX K141868 (possible match, unconfirmed).

What the differences mean

LYMA Laser is a low-level (“cold”) laser; Tria FRX is a non-ablative fractional laser. In use, LYMA Laser: no heat; the brand reports no pain or downtime. Tria FRX: warmth, prickling and short-lived redness are expected. They work in different ways, so they are not direct substitutes.

A low-level laser emits coherent near-infrared light at power that does not heat tissue. It works by photobiomodulation: light absorbed by the cell’s mitochondria changes cell signalling, which studies link to collagen production. It shares this mechanism with LED masks but uses a laser source.

A non-ablative fractional laser fires a grid of microscopic heat columns, called microthermal treatment zones, into the dermis. The skin between the columns stays intact and heals each zone quickly, which drives collagen remodelling. Wavelengths around 1440–1550 nm are absorbed by water in the skin, so the effect does not depend on skin pigment.

LYMA Laser

LYMA brought low-level laser therapy into the luxury home market, and its FDA record names the Laser directly: a cordless 808 nm wand with a diffused lens that the brand says works without heat, pain or downtime.

Suited to: Preferring a non-thermal treatment with no expected downtime; Treating face, neck and small body areas.

Tria FRX

Tria has held FDA clearances for home-use lasers since 2010, and the FRX is its second-generation fractional device: a 1440 nm non-ablative fractional laser that creates microscopic treatment zones, the same principle used by in-clinic resurfacing lasers.

Suited to: Texture, tone, dark spots and fine lines (brand indications); Willing to follow a structured 12-week programme.

Research matching both

All home lasers compared

Frequently asked questions

What is the main difference between LYMA Laser and Tria FRX?

LYMA Laser is a low-level (“cold”) laser; Tria FRX is a non-ablative fractional laser. In use, LYMA Laser: no heat; the brand reports no pain or downtime. Tria FRX: warmth, prickling and short-lived redness are expected. They work in different ways, so they are not direct substitutes.

Which is cheaper, LYMA Laser or Tria FRX?

Their reference prices are in different currencies (£1,999 and US$699.99) and we do not convert them. Check current prices on the manufacturer pages.

Which has more research behind it?

Of the studies we explain, 3 match LYMA Laser’s technology and wavelengths and 7 match Tria FRX’s. Matching studies did not necessarily test these models.